The #DeiBiopharma facility boasts a biotech facility, the first in Africa under US patent, which will produce the latest cancer drugs, biosimilars, peptides, cell therapy, biologics, cytokines, therapeutic proteins, gene therapy, and vaccines, including mRNA and others.

Ma'am,just a gentle reminder..last year,US FDA slapped Bengaluru facility of #Biocon ,that makes Biosimilars&auto-injectors for insulin products,with 7 scathing observations vide Form 483

You adopted corrective measures within 6 months;Loyal investors did not boo-boo the company!

Per excellent new IQVIA report: Utilization (more prescriptions, adherence) will drive U.S. drug spending, while net brand-name #drug prices will continue dropping due to #IRA , #biosimilars , generics, price cuts, #PBMs , etc.

Michael Kleinrock

==> drugch.nl/4b6H6Qw

Atomic IBD Uncut - Episode Eleven

• Cost of medicines
• Sustainable healthcare
• Biosimilars in IBD ten years on

Hearing from CPHO David Webb on
#OneTeam collaborative solutions +visible leadership4 #MedicinesOptimisation to deliver on #AMR (5yr Action plan), Innovation ATMPs/biosimilars/Genomics #overprescribing IP+pathfinders & data driven outcomes inc Pharmacy1st

📸 En el diálogo con representantes de la industria farmacéutica y de dispositivos médicos encabezado por la canciller Alicia Bárcena, se mencionó que los laboratorios de la región tienen un papel fundamental en la producción de medicamentos innovadores, biosimilares y genéricos,

📢¡Actualización de la sección #Biosimilares en cifras!📢

👏Ya disponible la información de enero a diciembre de 2023

¿Quieres conocer los datos sobre biosimilares en España, hospital y oficina de farmacia?

Aquí verás👇
✅Consumo actual
✅Evolución
✅Principios activos con

Biosimilars | Therapy | Business Performance

Part A: Biosimilars Market Share in the US

📸1: The market share for Ogivri® increased to 18% from 10% in the same period last year.

Fulphila® increased to 21% from 14% a year ago

Semglee® & our unbranded bGlargine MS improved to

$VKTX One significant concern is the competitor landscape and probable patent expiry for semaglutide in 2031 when cheap biosimilars flood the market. To get from phase 2 to approval in obesity, type 2 diabetes and a CV trial will take 4 + years

A $50B CHIPS-like Act for Domestic Drug Manufacturing?

The number of active drug shortages in the US is at a 10+ year high:

Why? Mainly the economics of generics (note: biosimilars are different):
- Manufacturers face severe margin compression, with >80% price cuts as multiple

The YKTM (Yoweri Kaguta Tibuhaburwa Museveni) GLP Biotech Laboratories, a crucial component of the facility, include components for cancer research, QA/QC, drug discovery, gene therapy, cell therapy, mRNA therapeutics, vaccines, biosimilars, and biologics. #DeiBioPharma

The facility boasts a biotech facility, the first in Africa under US patent, which will produce the latest cancer drugs, biosimilars, peptides, cell therapy, biologics, cytokines, therapeutic proteins, gene therapy, and vaccines, including mRNA and others. #DeiBioPharma

Biosimilars Revenue in FY24 Crosses USD 1 Bn, Biocon Biologics’ Revenue at Rs 8,824 Crore Up 58% (YoY)

RESEARCH SERVICES: Syngene
Revenue at Rs 3,489 Crore, Up 9% (YoY)

GENERICS: APIs & Generic Formulations Revenue at Rs 2,799 Crore, Up 1% (YoY)

Read more:

📅 21 May 2024
event entitled:
'ONE Biosimilars Webinar'
🟢 Registration
register.gotowebinar.com/register/63540…

The YKTM (Yoweri Kaguta Tibuhaburwa Museveni) GLP Biotech Laboratories, a crucial component of the facility, include components for cancer research, QA/QC, drug discovery, gene therapy, cell therapy, mRNA therapeutics, vaccines, biosimilars, and biologics.

#DeiBiopharma

Regresamos del 50 Congreso Nacional de la SER en Gran Canaria, llenos de entusiasmo!

Exploramos las últimas tendencias en tratamiento y diagnóstico de enfermedades reumáticas, destacando los #biosimilares .
¡Gracias a Soc.Esp.Reumatología y a todos los participantes!

#SER2024

La llegada de los #biosimilares ha marcado📍un antes y un después en el manejo clínico🧑‍⚕️de las enfermedades inflamatorias intestinales #EII , permitiendo el #EarlyTreatment con anti-TNF en primeras líneas de #tratamiento

A partir de una base de datos de varios hospitales

The facility boasts a biotech facility, the first in Africa under US patent, which will produce the latest cancer drugs, biosimilars, peptides, cell therapy, biologics, cytokines, therapeutic proteins, gene therapy, and vaccines, including mRNA and others.

#DeiBiopharma

A diferencia de los medicamentos convencionales, que están hechos de productos químicos, los productos biológicos se elaboran o se extraen de células u organismos vivos como bacterias, plantas o animales.

formulamedica.com.co/no-dejes-de-le…

#FormulaMedica #Biosimilares